Validation of an Obstetric QoR Score and to Establish Its MCID.
NCT ID: NCT03711552
Last Updated: 2019-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2018-10-31
2019-07-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Translation and Validation of the French Version of the ObsQoR-10 Questionnaire
NCT04489602
Postpartum Quality of Recovery & Maternal Satisfaction After C/S
NCT05077891
Validation of the Chinese ObsQoR-11
NCT04349215
Quality of Recovery After Unplanned and Planned Cesarean Deliveries - an Application of ObsQoR-10
NCT04907292
Improving ObsQoR-11 With Continuous Wound Infusion Versus Intrathecal Morphine After Elective Cesarean Delivery
NCT05696678
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The validation of the ObsQoR-11 score will follow as per the Consensus based Standards for the selection of health Measurement Instruments (COSMIN) initiative. The assessment tool will be evaluated under the domains of validity, reliability, responsiveness and feasibility. The QoR-15 score will be similarly assessed to allow a comparison.
Validity will be assessed using two separate methods:
1. Convergent and discriminant validity - Comparison of the ObsQoR-11 score to 100mm Global health score.
2. Content validity - ObsQoR-11 will be assessed for correlation with patient age and length of hospital stay.
Reliability as a measure of consistency will be assessed based on the following methods:
1. Internal consistency - the averaged correlation between each of the items within theObsQoR-11.
2. Split half reliability - assessed by evaluating the correlation between random split segments.
3. Test-retest reliability - a subset of patients will be reassessed at 30-60 minutes and the correlation between scores assessed.
4. Floor and ceiling effects - this will be evaluated by whether \<15% of patients achieved the highest (110/110) or lowest (0/110) possible scores.
Responsiveness is a measure of the ability to detect a clinically important change.
1. Cohen effect size - the mean change in scores from before surgery to 24 hours after surgery divided by the standard deviation at baseline.
2. Standardised response mean - the change in the scores before surgery to 24 hours after surgery divided by the standard deviation of the change in scores.
3. Mean ObsQoR-11 scores - mean scores compared before surgery to 24 hours after surgery.
Feasibility
1. Assessment of recruitment rate.
2. Successful recruitment rate.
3. Time taken to complete the ObsQoR-11.
The MCID will be determined based on an anchor-based method. The change in the mean score of the ObsQoR-11 score will be compared to the patient's own assessment of her change in health status using a Likert scale. We opted to follow a similar statistical method from an influential paper for estimation of the MCID. This will be based on calculation of the 0.3 SD (standard deviation), SEM (standard error of the mean) and the 5% range.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Quality of recovery
All enrolled patients will be asked to complete the ObsQoR-11 and QoR-15 questionnaires pre-surgery if feasible and at 24 and 48 hours post-surgery.
ObsQoR-11
Quality of recovery questionnaire
QoR-15
Quality of recovery questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ObsQoR-11
Quality of recovery questionnaire
QoR-15
Quality of recovery questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \>18 years.
Exclusion Criteria
* Patient refusal.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Coombe Women and Infants University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ruairi Irwin
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Terry Tan
Role: STUDY_DIRECTOR
Head of Department of Anaesthesia CWIUH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Coombe Women and Infants University Hospital
Dublin, , Ireland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CWIUH-QoR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.